AstraZeneca, Cephalon to pay to resolve Medicaid allegations: U.S.

WASHINGTON AstraZeneca LP has agreed to pay $46.5 million and Cephalon Inc [TEVAE.UL] $7.5 million to resolve allegations that the two drug companies underpaid rebates owed under the Medicaid program, the U.S. Justice Department said on Monday.

(Reporting by Eric Beech– Editing by Bill Trott)